Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice

Atsuki Imaeda, Shota Tanaka, Kota Tonegawa, Shota Fuchigami, Masanori Obana, Makiko Maeda, Miho Kihara, Hiroshi Kiyonari, Simon Conway, Yasushi Fujio, Hiroyuki Nakayama

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Abnormal β-adrenergic signaling plays a central role in human heart failure. In mice, chronic β-adrenergic receptor (βAR) stimulation elicits cardiac hypertrophy. It has been reported that cultured cardiac fibroblasts express βAR; however, the functional in vivo requirement of βAR signaling in cardiac fibroblasts during the development of cardiac hypertrophy remains elusive. β2AR null mice exhibited attenuated hypertrophic responses to chronic βAR stimulation upon continuous infusion of an agonist, isoprenaline (ISO), compared to those in wildtype controls, suggesting that β2AR activation in the heart induces pro-hypertrophic effects in mice. Since β2AR signaling is protective in cardiomyocytes, we focused on β2AR signaling in cardiac myofibroblasts. To determine whether β2AR signaling in myofibroblasts affects cardiac hypertrophy, we generated myofibroblast-specific transgenic mice (TG) with the catalytic subunit of protein kinase A (PKAcα) using Cre-loxP system. Myofibroblast-specific PKAcα overexpression resulted in enhanced heart weight normalized to body weight ratio, associated with an enlargement of cardiomyocytes at 12 weeks of age, indicating that myofibroblast-specific activation of PKA mediates cardiac hypertrophy in mice. Neonatal rat cardiomyocytes stimulated with conditioned media from TG cardiac fibroblasts likewise exhibited significantly more growth than those from controls. Thus, β2AR signaling in myofibroblasts plays a substantial role in ISO-induced cardiac hypertrophy, possibly due to a paracrine effect. β2AR signaling in cardiac myofibroblasts may represent a promising target for development of novel therapies for cardiac hypertrophy.

Original languageEnglish (US)
Pages (from-to)149-155
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume510
Issue number1
DOIs
StatePublished - Feb 26 2019

Fingerprint

Myofibroblasts
Cardiomegaly
Adrenergic Agents
Adrenergic Receptors
Fibroblasts
Cardiac Myocytes
Isoproterenol
Transgenic Mice
Chemical activation
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits
Conditioned Culture Medium
Rats
Heart Failure
Body Weight
Weights and Measures
Growth

Keywords

  • Cardiac fibroblast
  • Cardiac hypertrophy
  • Paracrine effect
  • Protein kinase A
  • β-adrenergic receptor

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Imaeda, A., Tanaka, S., Tonegawa, K., Fuchigami, S., Obana, M., Maeda, M., ... Nakayama, H. (2019). Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice. Biochemical and Biophysical Research Communications, 510(1), 149-155. https://doi.org/10.1016/j.bbrc.2019.01.070

Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice. / Imaeda, Atsuki; Tanaka, Shota; Tonegawa, Kota; Fuchigami, Shota; Obana, Masanori; Maeda, Makiko; Kihara, Miho; Kiyonari, Hiroshi; Conway, Simon; Fujio, Yasushi; Nakayama, Hiroyuki.

In: Biochemical and Biophysical Research Communications, Vol. 510, No. 1, 26.02.2019, p. 149-155.

Research output: Contribution to journalArticle

Imaeda, A, Tanaka, S, Tonegawa, K, Fuchigami, S, Obana, M, Maeda, M, Kihara, M, Kiyonari, H, Conway, S, Fujio, Y & Nakayama, H 2019, 'Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice', Biochemical and Biophysical Research Communications, vol. 510, no. 1, pp. 149-155. https://doi.org/10.1016/j.bbrc.2019.01.070
Imaeda, Atsuki ; Tanaka, Shota ; Tonegawa, Kota ; Fuchigami, Shota ; Obana, Masanori ; Maeda, Makiko ; Kihara, Miho ; Kiyonari, Hiroshi ; Conway, Simon ; Fujio, Yasushi ; Nakayama, Hiroyuki. / Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice. In: Biochemical and Biophysical Research Communications. 2019 ; Vol. 510, No. 1. pp. 149-155.
@article{99976079fa794dcaa66387b1bc3b22c1,
title = "Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice",
abstract = "Abnormal β-adrenergic signaling plays a central role in human heart failure. In mice, chronic β-adrenergic receptor (βAR) stimulation elicits cardiac hypertrophy. It has been reported that cultured cardiac fibroblasts express βAR; however, the functional in vivo requirement of βAR signaling in cardiac fibroblasts during the development of cardiac hypertrophy remains elusive. β2AR null mice exhibited attenuated hypertrophic responses to chronic βAR stimulation upon continuous infusion of an agonist, isoprenaline (ISO), compared to those in wildtype controls, suggesting that β2AR activation in the heart induces pro-hypertrophic effects in mice. Since β2AR signaling is protective in cardiomyocytes, we focused on β2AR signaling in cardiac myofibroblasts. To determine whether β2AR signaling in myofibroblasts affects cardiac hypertrophy, we generated myofibroblast-specific transgenic mice (TG) with the catalytic subunit of protein kinase A (PKAcα) using Cre-loxP system. Myofibroblast-specific PKAcα overexpression resulted in enhanced heart weight normalized to body weight ratio, associated with an enlargement of cardiomyocytes at 12 weeks of age, indicating that myofibroblast-specific activation of PKA mediates cardiac hypertrophy in mice. Neonatal rat cardiomyocytes stimulated with conditioned media from TG cardiac fibroblasts likewise exhibited significantly more growth than those from controls. Thus, β2AR signaling in myofibroblasts plays a substantial role in ISO-induced cardiac hypertrophy, possibly due to a paracrine effect. β2AR signaling in cardiac myofibroblasts may represent a promising target for development of novel therapies for cardiac hypertrophy.",
keywords = "Cardiac fibroblast, Cardiac hypertrophy, Paracrine effect, Protein kinase A, β-adrenergic receptor",
author = "Atsuki Imaeda and Shota Tanaka and Kota Tonegawa and Shota Fuchigami and Masanori Obana and Makiko Maeda and Miho Kihara and Hiroshi Kiyonari and Simon Conway and Yasushi Fujio and Hiroyuki Nakayama",
year = "2019",
month = "2",
day = "26",
doi = "10.1016/j.bbrc.2019.01.070",
language = "English (US)",
volume = "510",
pages = "149--155",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice

AU - Imaeda, Atsuki

AU - Tanaka, Shota

AU - Tonegawa, Kota

AU - Fuchigami, Shota

AU - Obana, Masanori

AU - Maeda, Makiko

AU - Kihara, Miho

AU - Kiyonari, Hiroshi

AU - Conway, Simon

AU - Fujio, Yasushi

AU - Nakayama, Hiroyuki

PY - 2019/2/26

Y1 - 2019/2/26

N2 - Abnormal β-adrenergic signaling plays a central role in human heart failure. In mice, chronic β-adrenergic receptor (βAR) stimulation elicits cardiac hypertrophy. It has been reported that cultured cardiac fibroblasts express βAR; however, the functional in vivo requirement of βAR signaling in cardiac fibroblasts during the development of cardiac hypertrophy remains elusive. β2AR null mice exhibited attenuated hypertrophic responses to chronic βAR stimulation upon continuous infusion of an agonist, isoprenaline (ISO), compared to those in wildtype controls, suggesting that β2AR activation in the heart induces pro-hypertrophic effects in mice. Since β2AR signaling is protective in cardiomyocytes, we focused on β2AR signaling in cardiac myofibroblasts. To determine whether β2AR signaling in myofibroblasts affects cardiac hypertrophy, we generated myofibroblast-specific transgenic mice (TG) with the catalytic subunit of protein kinase A (PKAcα) using Cre-loxP system. Myofibroblast-specific PKAcα overexpression resulted in enhanced heart weight normalized to body weight ratio, associated with an enlargement of cardiomyocytes at 12 weeks of age, indicating that myofibroblast-specific activation of PKA mediates cardiac hypertrophy in mice. Neonatal rat cardiomyocytes stimulated with conditioned media from TG cardiac fibroblasts likewise exhibited significantly more growth than those from controls. Thus, β2AR signaling in myofibroblasts plays a substantial role in ISO-induced cardiac hypertrophy, possibly due to a paracrine effect. β2AR signaling in cardiac myofibroblasts may represent a promising target for development of novel therapies for cardiac hypertrophy.

AB - Abnormal β-adrenergic signaling plays a central role in human heart failure. In mice, chronic β-adrenergic receptor (βAR) stimulation elicits cardiac hypertrophy. It has been reported that cultured cardiac fibroblasts express βAR; however, the functional in vivo requirement of βAR signaling in cardiac fibroblasts during the development of cardiac hypertrophy remains elusive. β2AR null mice exhibited attenuated hypertrophic responses to chronic βAR stimulation upon continuous infusion of an agonist, isoprenaline (ISO), compared to those in wildtype controls, suggesting that β2AR activation in the heart induces pro-hypertrophic effects in mice. Since β2AR signaling is protective in cardiomyocytes, we focused on β2AR signaling in cardiac myofibroblasts. To determine whether β2AR signaling in myofibroblasts affects cardiac hypertrophy, we generated myofibroblast-specific transgenic mice (TG) with the catalytic subunit of protein kinase A (PKAcα) using Cre-loxP system. Myofibroblast-specific PKAcα overexpression resulted in enhanced heart weight normalized to body weight ratio, associated with an enlargement of cardiomyocytes at 12 weeks of age, indicating that myofibroblast-specific activation of PKA mediates cardiac hypertrophy in mice. Neonatal rat cardiomyocytes stimulated with conditioned media from TG cardiac fibroblasts likewise exhibited significantly more growth than those from controls. Thus, β2AR signaling in myofibroblasts plays a substantial role in ISO-induced cardiac hypertrophy, possibly due to a paracrine effect. β2AR signaling in cardiac myofibroblasts may represent a promising target for development of novel therapies for cardiac hypertrophy.

KW - Cardiac fibroblast

KW - Cardiac hypertrophy

KW - Paracrine effect

KW - Protein kinase A

KW - β-adrenergic receptor

UR - http://www.scopus.com/inward/record.url?scp=85060201763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060201763&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2019.01.070

DO - 10.1016/j.bbrc.2019.01.070

M3 - Article

C2 - 30683314

AN - SCOPUS:85060201763

VL - 510

SP - 149

EP - 155

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -